NYSE
CAH
Last Price
US $238.94
KEY FIGURES
MKT CAP
$55.7B
EPS
TTM
$6.63
PEG
TTM
17.94x
P/E
TTM
36.27x
P/S
TTM
0.25x
YIELD
0.86%
GROWTH
Revenue Y/Y
Profit margin
Current Ratio
Capital Returns
-55.72%
Return on equity
ROIC: 11.62%
Valuation History
36.3X
Price to Earnings
EV/EBITDA: 20.1X
Cash flow
Profit margin
7.80%
(FY vs FY)
EBITDA Y/Y
-
(FY vs FY)
Cash flow Y/Y
3.14%
(FY vs FY)
Cash Flow (DCF)
Fair Value
Market $238.94
-65.71%
Default assumptions
EBITDA Multiple
Fair Value
Market $238.94
-71.06%
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.
Valuation
Financial
Performance
Financial stability - Cash flow debt coverage.
Cardinal Health, Inc. cash flow to debt ratio of 25.65% indicates that the company generates enough cash to cover its debts. This level indicates strong financial health.
Financial risk - Healthy cash flow growth.
Cardinal Health, Inc.'s free cash flow has decreased -43.09% from $3.25G last year to $1.85G, signaling decreasing performance
Financial risk - Healthy debt to equity ratio.
Cardinal Health, Inc.'s debt to equity ratio is -3.15, signaling that the company spent its equity and risk bankruptcy.
Financial risk - Healthy debt to equity ratio development.
Cardinal Health, Inc.'s debt to equity ratio is -3.15, signaling that the company spent its equity and risk bankruptcy.
Financial stability - Net debt/EBITDA.
Cardinal Health, Inc. has a net debt to EBITDA ratio of 1.76x, which is below the 3.00x threshold, indicating healthy leverage and financial stability
Financial stability - ICR.
Cardinal Health, Inc.'s interest coverage ratio of 6.74 indicates that earnings with good margin can cover interest payments on company debt
Financial stability - Profit margin growth.
Cardinal Health, Inc.'s profit margin has increased (65.65%) in the last year from 0.38% to 0.62%, signaling increasing performance
Financial risk - Short term assets vs short term liabilities.
Cardinal Health, Inc.'s short-term liabilities of $38.90G exceed its short-term assets of $36.37G, signaling financial risk
Decreasing performance - ROA.
Cardinal Health, Inc.'s return on assets of 2.75% is lower than the 5.00% threshold, indicating inefficient asset utilization
Decreasing performance - Absolute return on equity.
Cardinal Health, Inc.'s return on equity of -55.72%, is lower than 15.00%, indicating bad performance
Increasing performance - Earnings quality.
Cardinal Health, Inc.'s operating cash flow exceeds its net income, indicating high-quality earnings backed by actual cash generation
Increasing performance - Earnings stability.
Cardinal Health, Inc. had positive net income in 4.00 out of 5 years, indicating stable and consistent earnings
Increasing performance - Free cash flow.
Cardinal Health, Inc. has positive free cash flow, indicating the company generates cash after capital expenditures
Increasing performance - FCF yield.
Cardinal Health, Inc. has a free cash flow yield of 3.32%, which is above the 2.00% threshold, indicating strong cash generation relative to market value
Increasing performance - Healthy earnings growth.
Cardinal Health, Inc.'s yearly earnings has increased 83.22% since last year from $852.00M to $1.56G, signaling increasing performance
Decreasing performance - Healthy revenue growth.
Cardinal Health, Inc.'s yearly revenue has decreased -1.87% since last year from $226.83G to $222.58G, signaling decreasing performance
Increasing performance - ROIC.
ROIC 11.62% (Source: FMP key-metrics). At or above the 10% threshold. Score: 2 of 2. The company is generating returns above the upper end of the typical US weighted-average cost of capital range under this definition of invested capital.
Increasing performance - 3-year revenue CAGR.
Cardinal Health, Inc.'s 3-year revenue CAGR of 7.07% is positive, indicating growing revenue over the past 3 years
Increasing performance - Revenue consistency.
Cardinal Health, Inc. had revenue growth in 4.00 out of 5 years, indicating consistent revenue performance
Decreasing performance - ROE consistency.
Cardinal Health, Inc. had positive ROE in only 1.00 out of 5 years, indicating inconsistent returns on equity
Overvalued - DCF valuation.
Cardinal Health, Inc. is overvalued relative to its fair value price of 81.94 based on Discounted Cash Flow model
Overvalued - Earnings yield.
Cardinal Health, Inc. has an earnings yield of 2.79%, which is below the 4.00% threshold, indicating the stock may be expensive relative to its earnings
Overvalued - EBITDA valuation.
Cardinal Health, Inc. is overvalued relative to its fair value price of 69.15 based on EBITDA multiple model
Overvalued - EV/EBITDA.
Cardinal Health, Inc. has an EV/EBITDA ratio of 20.06x, which exceeds the 20.00x threshold, indicating the stock may be overvalued relative to its operating earnings
Overvalued - PEG ratio value.
Cardinal Health, Inc. has a PEG-ratio over 1 which is considered overvalued
Overvalued - P/B ratio.
Cardinal Health, Inc. has negative shareholder equity; price-to-book is not meaningful and the check fails
Undervalued - P/S ratio.
Cardinal Health, Inc. has a price-to-sales ratio of 0.22x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue